Latest news
Entrada Therapeutics (Nasdaq: TRDA) reports Q2 2026 results and sets DMD, DM1 data timeline - Stock TitanStock Titan · Wed, 05 Aug 2026 11:04:58 GMTEntrada Therapeutics (TRDA) holder sells shares, still reports 1.09M stake - Stock TitanStock Titan · Mon, 03 Aug 2026 21:33:18 GMTDesign Therapeutics (NASDAQ: DSGN) highlights FA data alongside Q2 loss - Stock TitanStock Titan · Mon, 03 Aug 2026 12:08:26 GMTEntrada Therapeutics, Inc. SEC Filing (Jul 30, 2026) - Stock TitanStock Titan · Thu, 30 Jul 2026 07:00:00 GMTDyne Therapeutics (NASDAQ: DYN) details $299M loss, advances DMD and DM1 drugs - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT